Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells. - Wikidata - awgldk - TriplyDB

Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells.

Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells.

http://www.wikidata.org/entity/Q34442444

about

Insights into Group 2 Innate Lymphoid Cells in Human Airway Disease The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases.Early local immune defences in the respiratory tract IL-33 drives airway hyper-responsiveness through IL-13-mediated mast cell: airway smooth muscle crosstalk.The Effects of Antigen-Specific IgG1 Antibody for the Pulmonary-Hypertension-Phenotype and B Cells for Inflammation in Mice Exposed to Antigen and Fine Particles from Air Pollution.Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway Mast cells in airway diseases and interstitial lung disease Innate lymphoid cells: new insights into function and development.Controlling the burn and fueling the fire: defining the role for the alarmin interleukin-33 in alloimmunity IL-6 and IL-17A degradation by mast cells is mediated by a serglycin:serine protease axis Genetic variant in IL-33 is associated with idiopathic recurrent miscarriage in Chinese Han population.Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33.Alternative splicing of interleukin-33 and type 2 inflammation in asthma.Disruption of the TWEAK/Fn14 pathway prevents 5-fluorouracil-induced diarrhea in mice.New dog and new tricks: evolving roles for IL-33 in type 2 immunity.IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis.Group 2 innate lymphoid cells in disease.Immune dysregulation in the functional gastrointestinal disorders.Mast cells in asthma--state of the art.A novel isoform of IL-33 revealed by screening for transposable element promoted genes in human colorectal cancer Interleukin 33 is a guardian of barriers and a local alarmin.Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy.Interleukin 33: an innate alarm for adaptive responses beyond Th2 immunity-emerging roles in obesity, intestinal inflammation, and cancer.Interleukin-33 in health and disease.Alarmins: Feel the Stress.SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors.Allergic airway inflammation: key players beyond the Th2 cell pathway.IL-33: biological properties, functions, and roles in airway disease.New perspectives on the regulation of type II inflammation in asthma.The role of rare innate immune cells in Type 2 immune activation against parasitic helminths.Cell death and inflammation: the case for IL-1 family cytokines as the canonical DAMPs of the immune system.IL-4 production by group 2 innate lymphoid cells promotes food allergy by blocking regulatory T-cell function.Extracellular IL-33 cytokine, but not endogenous nuclear IL-33, regulates protein expression in endothelial cells Dectin-1 signaling inhibits osteoclastogenesis via IL-33-induced inhibition of NFATc1.IL-33 released by alum is responsible for early cytokine production and has adjuvant properties.IL-1 Family Cytokines Use Distinct Molecular Mechanisms to Signal through Their Shared Co-receptor.HpARI Protein Secreted by a Helminth Parasite Suppresses Interleukin-33 IL-33 promotes food anaphylaxis in epicutaneously sensitized mice by targeting mast cells.Androgen signaling negatively controls group 2 innate lymphoid cells.

P2860

Q28076134-C62BFFAD-A976-4CC7-AA49-9607CD637DAA Q33593742-11202469-BE84-47A4-B58D-C1BF8F891588 Q33824093-F5F6947C-52D2-41BC-B729-649D232CAE53 Q35565295-E4B603A0-19CA-4A05-9053-47364C5DE100 Q35665034-556683E2-CDD1-4BD5-8A0A-B4ADF5DC3AB5 Q35754479-793C7DA8-FF1D-4812-A7C9-DC0848E5F07B Q36119388-F4EB4020-B554-47C9-90A1-EA5630B7BAE8 Q36260500-466A1CB8-B655-4C67-91E9-C44B75984E09 Q36288830-B1D12F41-83CE-40F2-8722-BE314C0FF112 Q36440299-D51F9EB7-7DCE-4ACA-8A85-392A5EC074D3 Q36621030-233443D6-223B-4B71-808D-D4B518332864 Q36741487-E71D095B-D9B5-43A0-9825-5CD66DF8B333 Q36744984-622A182D-B517-4D9F-8426-30ACE0BA8E5A Q37161547-058D7DDA-CDE4-4DF5-97F6-A5FA70F42515 Q37742981-6C4938E6-1DDD-45D8-85AA-043AE7F3FBF3 Q38388349-9863AFEF-F9A8-4960-A41F-822E21590878 Q38438511-9F6C7D6E-321C-42B7-A726-34AA30AF09E5 Q38573631-8DBA0075-F6F5-4067-BA40-B25423B3089E Q38601401-2B1E08BB-A1BB-43AC-B565-AB6956632EC5 Q38633155-80805469-2EF9-48F8-ADEF-5482DACC5998 Q38675614-8AE89036-9B1A-402E-AB23-EFD747DDC42C Q38702558-C88F7B91-8E83-4233-8306-176A4D3CC865 Q38753216-A623C2B9-2746-4D62-940F-0AEC5CC8DFB7 Q38783993-2E4DFE8F-769E-4A2D-A0B1-7CDE9C3782C0 Q38957840-761C6CBB-1D9D-45C3-B670-11C4FDCC040B Q39123275-536E98F0-ED31-4783-922D-E79B95039DEE Q39276466-686AC88E-9F73-4200-9275-768F251809AD Q39402866-2D54BFFD-E99A-4369-A069-DB3723521A88 Q39402943-61E8C9C3-959F-4FA7-A721-98E27C44F1BF Q39442990-918F3E01-C677-423A-8EC9-E79E7B346DED Q40184625-3078B0A4-1871-4C3F-9493-84CD3EF2F357 Q40641396-539F68A6-2DCB-426B-BA02-A427D18B2753 Q41036719-18ADEC10-14E1-4C5A-A722-DC8F9D6531DF Q41267861-BB345DCD-2F03-4706-A60E-A1FFFA79085F Q41593171-6ABD50BA-3EE9-4D98-85F2-F4A4F87B7213 Q41842923-FE262503-B265-4BAE-9111-043B382F4C18 Q41933760-19E6913A-B30B-415A-8655-3B5674D1C2D8 Q42635953-7955AB9A-0FE7-4B5F-899A-CADE9B8A999C Q42736146-668FE2B4-45B1-4584-8854-4FF55F333DBF Q44943990-A87C07E5-A2EA-4943-91C6-F49F0BE92376

P2860

Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells.

http://www.wikidata.org/entity/Q34442444

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Central domain of IL-33 is cle ...... group-2 innate lymphoid cells.

@ast

Central domain of IL-33 is cle ...... group-2 innate lymphoid cells.

@en

Central domain of IL-33 is cle ...... group-2 innate lymphoid cells.

@nl

type

label

Central domain of IL-33 is cle ...... group-2 innate lymphoid cells.

@ast

Central domain of IL-33 is cle ...... group-2 innate lymphoid cells.

@en

Central domain of IL-33 is cle ...... group-2 innate lymphoid cells.

@nl

prefLabel

Central domain of IL-33 is cle ...... group-2 innate lymphoid cells.

@ast

Central domain of IL-33 is cle ...... group-2 innate lymphoid cells.

@en

Central domain of IL-33 is cle ...... group-2 innate lymphoid cells.

@nl

P1433

Q34442444-EF65FA06-0B00-4E37-8D17-BF3E965ACD97

P1476

Q34442444-5A25D4AA-B7B6-4E95-99F1-A4723F0470DC

P2093

Q34442444-2124C4B7-484D-424F-A59D-F10C56524D7F

Q34442444-5D41B7F3-EB6C-4CEB-AF32-89A3E9F3D3D2

Q34442444-DA6DA022-7417-437E-B6DE-EB9BCC71A616

Q34442444-EDFAC2EF-46B4-439E-87C6-09FC26543339

Q34442444-FEECA5AE-7C65-4291-B43B-DFD3CF78F8F8

P2860

Q34442444-027422A8-B3EB-45FD-8700-14A8621867B7

Q34442444-02947605-90DB-4394-A1CB-9E23AE00924B

Q34442444-076187E5-586F-45E5-8DA5-F5C653172383

Q34442444-07C2E8D8-FE09-46C2-B6A7-3957B4F065F5

Q34442444-097D0B99-70D0-4543-A317-0813E9D0F1D2

Q34442444-0F27C709-D69F-4B89-9B11-4DC886089451

Q34442444-259D53F1-2F59-40BE-8AF7-A4C588F8D6F2

Q34442444-2FBA655C-F5BA-4EDD-94C6-01D1AB29C685

Q34442444-378D1BD2-428C-4627-B559-289FA48F0FCB

Q34442444-3A34790A-715E-445F-895F-F74991804E34

P304

Q34442444-9561C1AD-474F-468C-8EAF-343A22FC529F

P31

Q34442444-93A27292-C489-41C2-985F-C967EFE0AEA9

P356

Q34442444-7A7D66F7-524E-4DDC-890C-6F806B6BC869

P407

Q34442444-9FEC1C0D-1EC3-4467-AB79-596A73FDE1AB

P433

Q34442444-E3E12BA0-C37C-4CB4-9313-F516CDB745D0

P478

Q34442444-3A1E8400-A092-4AFD-9016-485BEBE3111B

P50

Q34442444-22B97E95-4DB4-498E-9F9B-38CF407E5F09

Q34442444-7141E0BA-7FD0-479D-8AB2-CD30BF604573

P577

Q34442444-83832CB8-A4A8-4B9F-A8ED-FA7304E2B0AE

P5875

Q34442444-639F220D-2235-4A16-B19D-12A7E61FECA6

P698

Q34442444-DF74FA09-51F1-45F5-A585-4EC69201EFF4

P921

Q34442444-86E5FD94-238E-425C-8EFD-E1EED8DE61B0

P932

Q34442444-5AC61A5D-17C2-42BB-84D4-B9929E7F8CC6

P356

PNAS.1410700111

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Central domain of IL-33 is cle ...... group-2 innate lymphoid cells.

@en

P2093

Anais Duval

http://www.w3.org/2001/XMLSchema#string

Emilie Mirey

http://www.w3.org/2001/XMLSchema#string

Emma Lefrançais

http://www.w3.org/2001/XMLSchema#string

Jean-Philippe Girard

http://www.w3.org/2001/XMLSchema#string

Stéphane Roga

http://www.w3.org/2001/XMLSchema#string

P2860

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket

Systemically dispersed innate IL-13-expressing cells in type 2 immunity

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G

The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1

Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules

Structural insights into the interaction of IL-33 with its receptors

Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain

A large-scale, consortium-based genomewide association study of asthma

P304

15502-15507

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1410700111

http://www.w3.org/2001/XMLSchema#string

P407

P433

43

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267749462

http://www.w3.org/2001/XMLSchema#string

P698

25313073

http://www.w3.org/2001/XMLSchema#string

P921

P932

4217470

http://www.w3.org/2001/XMLSchema#string